Morrisville, NC – September 25, 2024– BioBridges, a leading provider of people and technology solutions for the life sciences industry, announces the launch of a dedicated MedTech division.
As the MedTech industry undergoes significant transformation, driven by advances in AI and shifting regulatory landscapes, BioBridges is poised to support companies navigating these changes.
"While BioBridges has always had a strong presence in MedTech, this new division represents our commitment to offering more targeted and specialized support for our clients," says Mark Bouck Chairman and CEO. "Our goal is to bring the right people and solutions to market, enabling our clients to develop and launch products that will improve patient health."
The MedTech landscape is on the cusp of revolutionary change, with AI technologies playing a pivotal role in reshaping how medical devices are designed, developed, and regulated. From AI-driven diagnostic tools to personalized treatment plans, these innovations promise to enhance patient outcomes, reduce costs, and streamline regulatory approvals. However, this rapid technological advancement also presents challenges, particularly in navigating the complex and ever-evolving regulatory environment.
BioBridges' new MedTech division is designed to address these challenges head-on by providing flexible, tailored solutions that help companies bring their products to market efficiently and effectively.
By leveraging its deep industry expertise and global network of MedTech professionals, BioBridges ensures that clients have access to the best talent and resources, from discovery through commercialization.
"With the ongoing integration of AI into MedTech, companies are facing unprecedented opportunities and challenges," says James Goodmiller, Vice President of Client Services and leader of the new practice. "Our division is here to help them navigate these complexities, ensuring they have the right strategies and teams in place to succeed."
BioBridges has been a trusted partner in the life sciences industry for more than 20 years. With the launch of its new MedTech division, the company is reinforcing its dedication to supporting the development of cutting-edge medical technologies that improve patient care.
BioBridges delivers flexible solutions for life sciences companies from discovery through commercialization. Our global reach of expertise, services, and technologies empowers our clients to bring innovative solutions to the patients who need them.